Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

Pfizer Inc (PFE)

Xetra
Currency in EUR
24.410
+0.350(+1.45%)
Closed
PFE Scorecard
Full Analysis
Has raised its dividend for 14 consecutive years
High dividend Yield
Fair Value
Day's Range
24.25524.640
52 wk Range
23.25029.500
Key Statistics
Edit
Bid/Ask
24.41 / 24.41
Prev. Close
24.06
Open
24.295
Day's Range
24.255-24.64
52 wk Range
23.25-29.5
Volume
36.94K
Average Volume (3m)
59.26K
1-Year Change
-9.09%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PFE Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
32.600
Upside
+26.700%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year
Show more

Pfizer Inc Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women’s health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Employees
88000

Compare PFE to Peers and Sector

Metrics to compare
PFE
Peers
Sector
Relationship
P/E Ratio
34.1x−1.5x−0.7x
PEG Ratio
−0.570.030.00
Price/Book
1.6x2.4x2.6x
Price / LTM Sales
2.5x2.9x3.2x
Upside (Analyst Target)
-745.0%46.6%
Fair Value Upside
Unlock9.2%7.4%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.751
Dividend Yield
6.38%
Industry Median 2.40%
Annualised payout
1.5575
Paid quarterly
5-Years Growth
-
Growth Streak

FAQ

What Is the Pfizer (PFE) Stock Price Today?

The Pfizer stock price today is 24.41.

What Stock Exchange Does Pfizer Trade On?

Pfizer is listed and trades on the Xetra stock exchange.

What Is the Stock Symbol for Pfizer?

The stock symbol for Pfizer is "PFE."

Does Pfizer Pay Dividends? What’s The Current Dividend Yield?

The Pfizer Inc dividend yield is 6.51%.

What Is the Pfizer Market Cap?

As of today, Pfizer market cap is 137.94B.

What is Pfizer Earnings Per Share?

The Pfizer EPS is 0.751.

What Is the Next Pfizer Earnings Date?

Pfizer will release its next earnings report on 03 Feb 2025.

From a Technical Analysis Perspective, Is PFE a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.